Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers

by Brega, N., Dima, L., Drilon, A., Kummar, S., Lassen, U.N, Leyvraz, S., Lin, J.J, Liu, Y., Moreno, V., Norenberg, R., Patel, J.D, Rosen, L., Shen, L., Solomon, B., Tan, D.S.W
Published 2022

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

by Alcoceba, M., Benavente, Y., Berndt, S.I, Blanco, G., Butrym, A., Cabrera-Serrano, A.J, Campa, D., Canzian, F., Casabonne, D., Cerhan, J.R, Chen-Liang, T., Clay-Gilmour, A., de Sanjosé, S., Dierssen-Sotos, T., Espinet, B., Försti, A., Gámez, I., García-Álvarez, M., García-Martín, P., Giaccherini, M., Hemminki, K., Jerez, A., Landi, S., Li, Y., López-Nevot, M.Á, Luppi, M., Macauda, A., Maffei, R., Marasca, R., Marcos-Gragera, R., Moreno, V., Netea, M.G, Niazi, Y., Norman, A.D, Pérez, E.M, Puiggros, A., Rodríguez-Sevilla, J.J, Sainz, J., Sánchez-Maldonado, J.M, Slager, S.L, ter Horst, R., Thomsen, H.
Published 2023